Rhogam(d)immune globulin 300(25T/BX)

Ended Awarded Last action

Contract number
N0023216F5005
Awardee
Awarding agency
Obligated
$12,399

Award facts

Contract value 100% obligated
$12,398.58 Current and potential, with all options
Completion date
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Fort Lee, NJ 07024, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$1,860
Original award $14,258

About this award

This federal contract award is for the delivery of RHOGAM(D)IMMUNE GLOBULIN 300(25T/BX) to the Bureau of Medicine and Surgery, a component of the U.S. Navy. The $12,398.58 fixed-price delivery order was issued to Kedrion Biopharma Inc., a foreign-owned, for-profit manufacturer of plasma-derived pharmaceuticals. The order was placed against Kedrion's existing General Services Administration (GSA) Federal Supply Schedule 61-IB contract for Pharmaceuticals and Drugs. No set-aside provisions were used for this award. Kedrion has previously received other federal contracts and task orders from the Defense Health Agency, Department of the Army, and Department of the Navy to supply specialty plasma products like RHOGAM to treat rare and chronic conditions in the military and veteran populations. The company also holds a Blanket Purchase Agreement with the Department of Veterans Affairs worth up to $6 million for the supply of Ryplazim, a therapy for plasminogen deficiency.

Quick answers

Who was awarded contract N0023216F5005?

N0023216F5005 was awarded to Kedrion Biopharma Inc. by Bureau of Medicine and Surgery (Department of the Navy) on October 1, 2016.

How much is contract N0023216F5005 worth?

The government has obligated $12,399 on N0023216F5005.

Is contract N0023216F5005 an order under another contract?

Yes. N0023216F5005 is a delivery order under V797D30219, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract N0023216F5005 competed?

The extent of competition for N0023216F5005 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award